Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 347

    1.

    Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial.

    Hodis HN, Mack WJ, Lobo RA, Shoupe D, Sevanian A, Mahrer PR, Selzer RH, Liu Cr CR, Liu Ch CH, Azen SP; Estrogen in the Prevention of Atherosclerosis Trial Research Group.

    Ann Intern Med. 2001 Dec 4;135(11):939-53.PMID: 11730394 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Determinants of the effect of estrogen on the progression of subclinical atherosclerosis: Estrogen in the Prevention of Atherosclerosis Trial.

    Karim R, Mack WJ, Lobo RA, Hwang J, Liu CR, Liu CH, Sevanian A, Hodis HN.

    Menopause. 2005 Jul-Aug;12(4):366-73. Epub 2005 Jul 21.PMID: 16037751 [PubMed - indexed for MEDLINE]Related articles

    3.

    Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial.

    Mack WJ, Hameed AB, Xiang M, Roy S, Slater CC, Stanczyk FZ, Lobo RA, Liu CR, Liu CH, Hodis HN.

    Atherosclerosis. 2003 May;168(1):91-8.PMID: 12732391 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.

    Crouse JR 3rd, Raichlen JS, Riley WA, Evans GW, Palmer MK, O'Leary DH, Grobbee DE, Bots ML; METEOR Study Group.

    JAMA. 2007 Mar 28;297(12):1344-53. Epub 2007 Mar 25.PMID: 17384434 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Relationship between serum levels of sex hormones and progression of subclinical atherosclerosis in postmenopausal women.

    Karim R, Hodis HN, Stanczyk FZ, Lobo RA, Mack WJ.

    J Clin Endocrinol Metab. 2008 Jan;93(1):131-8. Epub 2007 Oct 9.PMID: 17925335 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of hormone replacement therapy on serum lipids in elderly women. a randomized, placebo-controlled trial.

    Binder EF, Williams DB, Schechtman KB, Jeffe DB, Kohrt WM.

    Ann Intern Med. 2001 May 1;134(9 Pt 1):754-60.PMID: 11329233 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Summaries for patients. Postmenopausal estrogen helps prevent atherosclerosis in some women.

    [No authors listed]

    Ann Intern Med. 2001 Dec 4;135(11):S-58. No abstract available. PMID: 11759662 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Inflammatory markers and progression of subclinical atherosclerosis in healthy postmenopausal women (from the Estrogen in the Prevention of Atherosclerosis Trial).

    Hodis HN, St John JA, Xiang M, Cushman M, Lobo RA, Mack WJ.

    Am J Cardiol. 2008 Apr 15;101(8):1131-3. Epub 2008 Feb 14.PMID: 18394446 [PubMed - indexed for MEDLINE]Related articles

    9.

    Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.

    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.

    Climacteric. 2002 Dec;5(4):341-50.PMID: 12626213 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of continuous estrogen and estrogen-progestin replacement regimens on cardiovascular risk markers in postmenopausal women.

    Davidson MH, Maki KC, Marx P, Maki AC, Cyrowski MS, Nanavati N, Arce JC.

    Arch Intern Med. 2000 Nov 27;160(21):3315-25.PMID: 11088095 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries.

    Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, Park JS, Salonen JT.

    Circulation. 1995 Oct 1;92(7):1758-64.PMID: 7671358 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

    MacMahon S, Sharpe N, Gamble G, Hart H, Scott J, Simes J, White H.

    Circulation. 1998 May 12;97(18):1784-90. Erratum in: Circulation 1996 Jun 23;97(24):2479. PMID: 9603532 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.

    Espeland MA, Applegate W, Furberg CD, Lefkowitz D, Rice L, Hunninghake D.

    Am J Epidemiol. 1995 Nov 15;142(10):1011-9.PMID: 7485045 [PubMed - indexed for MEDLINE]Related articles

    14.

    Postmenopausal oral estrogen therapy and blood pressure in normotensive and hypertensive subjects: the Estrogen in the Prevention of Atherosclerosis Trial.

    Steiner AZ, Hodis HN, Lobo RA, Shoupe D, Xiang M, Mack WJ.

    Menopause. 2005 Nov-Dec;12(6):728-33. Epub 2005 Nov 8.PMID: 16278616 [PubMed - indexed for MEDLINE]Related articles

    15.

    Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.

    Hodis HN, Mack WJ, Dunn M, Liu C, Liu C, Selzer RH, Krauss RM.

    Circulation. 1997 Apr 15;95(8):2022-6.PMID: 9133510 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS).

    Hodis HN, Mack WJ, LaBree L, Mahrer PR, Sevanian A, Liu CR, Liu CH, Hwang J, Selzer RH, Azen SP; VEAPS Research Group.

    Circulation. 2002 Sep 17;106(12):1453-9.PMID: 12234947 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women.

    Hodis HN, Mack WJ, Azen SP, Lobo RA, Shoupe D, Mahrer PR, Faxon DP, Cashin-Hemphill L, Sanmarco ME, French WJ, Shook TL, Gaarder TD, Mehra AO, Rabbani R, Sevanian A, Shil AB, Torres M, Vogelbach KH, Selzer RH; Women's Estrogen-Progestin Lipid-Lowering Hormone Atherosclerosis Regression Trial Research Group.

    N Engl J Med. 2003 Aug 7;349(6):535-45.PMID: 12904518 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial.

    Shukla A, Sharma MK, Jain A, Goel PK.

    Indian Heart J. 2005 Nov-Dec;57(6):675-80.PMID: 16521637 [PubMed - indexed for MEDLINE]Related articles

    19.

    Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.

    Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu C, Liu C, Alaupovic P, Kwong-Fu H, Azen SP.

    Ann Intern Med. 1996 Mar 15;124(6):548-56.PMID: 8597317 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women.

    Tremollieres FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C.

    Atherosclerosis. 2000 Nov;153(1):81-8.PMID: 11058702 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data